illumina Illumina

Illumina is a world leader in sequencing platforms and integrated systems for the analysis of genetic variation and biological function. By empowering genetic analysis research their tools accelerate disease discovery, drug development and the development of molecular tests in the clinic to help make personalised medicine a reality. Illumina has been an invaluable supporter of the Mission Massimo project allowing the identification of variations in the DARS gene associated with the newly classified condition Hypomyelination with Brain Stem and Spinal Cord Involvement and Leg Spasticity (HBSL).